- C.R. Bard (BCR -0.9%) Q3 results ($M): Revenues: 830.0 (+9.5%); Gross Profit: 521.1 (+11.8%); Operating Expenses: 315.1 (-2.5%); Operating Income: 180.3 (+51.5%); Net Income: 131.3 (+40.9%); EPS: 1.69 (+47.0%).
- Revenues by Product Group: Vascular: 231.5 (+10.3%); Urology: 209.6 (+8.2%); Oncology: 229.7 (+6.6%); Surgical Specialties: 135.6 (+14.8%); Other: 23.6 (+13.5%).
- No financial guidance given.